NorthRock Partners LLC Acquires 846 Shares of UnitedHealth Group Incorporated $UNH

NorthRock Partners LLC increased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 7.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,668 shares of the healthcare conglomerate’s stock after purchasing an additional 846 shares during the quarter. NorthRock Partners LLC’s holdings in UnitedHealth Group were worth $3,640,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Bayforest Capital Ltd increased its position in UnitedHealth Group by 685.7% in the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd grew its position in shares of UnitedHealth Group by 416.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock worth $32,000 after buying an additional 50 shares during the period. IAG Wealth Partners LLC acquired a new position in shares of UnitedHealth Group during the 1st quarter worth about $42,000. Kentucky Trust Co grew its position in shares of UnitedHealth Group by 53.8% during the 2nd quarter. Kentucky Trust Co now owns 143 shares of the healthcare conglomerate’s stock worth $45,000 after buying an additional 50 shares during the period. Finally, O Brien Wealth Partners LLC grew its position in shares of UnitedHealth Group by 74.0% during the 1st quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate’s stock worth $46,000 after buying an additional 37 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Trading Down 3.6%

Shares of UnitedHealth Group stock opened at $354.30 on Monday. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73. The stock has a market cap of $320.88 billion, a P/E ratio of 15.35, a P/E/G ratio of 2.29 and a beta of 0.47. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The business’s 50 day moving average is $318.21 and its 200-day moving average is $348.08.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter last year, the company posted $6.80 EPS. The firm’s revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is currently 38.30%.

Analyst Upgrades and Downgrades

UNH has been the subject of several analyst reports. Baird R W lowered UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research report on Thursday, July 31st. Cantor Fitzgerald reiterated an “overweight” rating and issued a $440.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, August 26th. Bank of America boosted their price objective on UnitedHealth Group from $350.00 to $390.00 and gave the company a “neutral” rating in a research report on Wednesday, October 8th. Sanford C. Bernstein boosted their price objective on UnitedHealth Group from $379.00 to $433.00 and gave the company an “outperform” rating in a research report on Wednesday, October 8th. Finally, Weiss Ratings reiterated a “sell (d+)” rating on shares of UnitedHealth Group in a research report on Wednesday, October 8th. Sixteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have given a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $383.09.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.